Area of research
Molecular Biology · Oncology
Research interest
Research interests include RNA regulation and disease, CAR-T cell therapy research, RNA Research and Splicing, and Immunotherapy and Immune Responses.
HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness
RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis
Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation
Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer
Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide
An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer
ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
Adenosine-to-Inosine RNA Editing Mediated by ADARs in Esophageal Squamous Cell Carcinoma
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in Mice